Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 350 participants.
Also called NCT01377285
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 350 participants
- Sponsor
- Registry
-
NCT01377285
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Taiwan
- Registry status
- Unknown status
Technical summary
Registry record NCT01377285. Randomized; quadruple masking; primary purpose treatment. Start 2010-06 (registry gives no type); primary completion 2018-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)
- Acronym
- CKD (chronic kidney disease)
- Condition
- Chronic Renal Failure
- Intervention (Drug)
- ARB
- Intervention (Drug)
- Pentoxifylline
- Intervention (Drug)
- Placebo (for Pentoxifylline)
- Lead sponsor
- National Taiwan University Hospital
- Collaborator
- Far Eastern Memorial Hospital
- Collaborator
- Mackay Memorial Hospital
- Collaborator
- Taipei Medical University Hospital
- Collaborator
- Shin Kong Wu Ho-Su Memorial Hospital
- Collaborator
- Cathay General Hospital
Record details
- Record id
cardio:ct-nct01377285- Content hash
137f170a2991e50df8ac55754ffd1bff2047de9e54b38fca11dc11f0dc240b08